ClearCut Medical is a commercial-stage medical device company that developed an innovative first-to-market compact MRI system for real time intraoperative margin assessment of excised tissue during breast-conserving cancer surgery (first application). The surgeon can instantly identify marginal areas suspected to be malignant without special training. There is no need to wait for interpretation by other specialists that are not present in the OR, and the surgeon can immediately proceed to remove the remaining malignant tissue without waiting days for a pathology report.